Login / Signup

COVID-19 and (hydroxy)chloroquine-azithromycin combination: Should we take the risk for our patients?

Hervé JavelotWissam El-HageGuillaume MeyerGuillaume BeckerBruno MichelCoraline Hingray
Published in: British journal of clinical pharmacology (2020)
Keyphrases
  • end stage renal disease
  • coronavirus disease
  • newly diagnosed
  • ejection fraction
  • prognostic factors
  • patient reported